D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
OceanFirst Financial
OCFC
$1.7B
| $241K | ﹤0.01% |
8,998
-7,144
| -44% | -$193K |
|
|
ELLI
3202
CALL
DELISTED
Ellie Mae Inc
ELLI
| $239K | ﹤0.01% |
2,600
| – | – |
|
3203
Aflac
AFL
$63.9B
| $238K | ﹤0.01% |
5,428
-228,236
| -98% | -$10.1M |
|
|
TEF
3204
DELISTED
Telefonica
TEF
| $238K | ﹤0.01% |
29,830
+13,104
| +78% | +$104K |
|
|
FOMX
3205
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $238K | ﹤0.01% |
46,426
+9,232
| +25% | +$55.6K |
|
3206
CALL
VeriSign
VRSN
$25.3B
| $237K | ﹤0.01% |
2,000
-35,200
| -95% | -$4.08M |
|
3207
Ingersoll Rand
IR
$33B
| $236K | ﹤0.01% |
7,708
-32,523
| -81% | -$1.08M |
|
3208
Microchip Technology
MCHP
$42.8B
| $236K | ﹤0.01% |
5,166
-548,040
| -99% | -$25.3M |
|
|
PRO
3209
DELISTED
PROS Holdings
PRO
| $235K | ﹤0.01% |
+7,129
| New | +$220K |
|
3210
PC Connection
CNXN
$2.05B
| $234K | ﹤0.01% |
9,362
+1,257
| +16% | +$32.5K |
|
3211
CALL
Generac Holdings
GNRC
$11.9B
| $234K | ﹤0.01% |
5,100
| – | – |
|
3212
PUT
Markel Group
MKL
$25B
| $234K | ﹤0.01% |
200
| – | – |
|
|
OPTU
3213
Optimum Communications Inc
OPTU
$316M
| $233K | ﹤0.01% |
+12,630
| New | +$259K |
|
3214
MGIC Investment
MTG
$6.27B
| $233K | ﹤0.01% |
17,961
-163,778
| -90% | -$2.32M |
|
|
NCI
3215
PUT
DELISTED
Navigant Consulting, Inc.
NCI
| $233K | ﹤0.01% |
12,100
| – | – |
|
|
ARRY
3216
DELISTED
Array Biopharma Inc
ARRY
| $232K | ﹤0.01% |
14,218
-222,218
| -94% | -$3.56M |
|
|
CYTR
3217
DELISTED
CytRx Corp
CYTR
| $232K | ﹤0.01% |
145,786
-173,646
| -54% | -$305K |
|
|
ABAX
3218
DELISTED
Abaxis Inc
ABAX
| $232K | ﹤0.01% |
3,282
-25,669
| -89% | -$1.72M |
|
3219
PUT
Hain Celestial
HAIN
$47.8M
| $231K | ﹤0.01% |
7,200
+1,300
| +22% | +$47.2K |
|
3220
Novavax
NVAX
$1.23B
| $231K | ﹤0.01% |
5,497
+1,313
| +31% | +$52.7K |
|
3221
Papa John's
PZZA
$999M
| $231K | ﹤0.01% |
4,037
-1,025
| -20% | -$61.3K |
|
3222
CALL
Xylem
XYL
$28.5B
| $231K | ﹤0.01% |
+3,000
| New | +$222K |
|
|
QHC
3223
DELISTED
Quorum Health Corporation
QHC
| $231K | ﹤0.01% |
28,344
+17,626
| +164% | +$116K |
|
3224
Banco de Chile
BCH
$20.6B
| $230K | ﹤0.01% |
7,005
-8,392
| -55% | -$279K |
|
3225
CALL
Enbridge
ENB
$124B
| $230K | ﹤0.01% |
+7,300
| New | +$256K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.